Perrigo VP Michael Robert Stewart Unloads 5,063 Shares (PRGO)
Perrigo (NASDAQ:PRGO) VP Michael Robert Stewart sold 5,063 shares of the company’s stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $123.37, for a total value of $624,622.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
PRGO has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo (NASDAQ:PRGO) in a research note to investors on Friday, August 16th. They now have a $128.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. set a $150.00 price target on shares of Perrigo (NASDAQ:PRGO) in a research note to investors on Friday, August 16th. They now have an “overweight” rating on the stock. Finally, analysts at Guggenheim raised their price target on shares of Perrigo (NASDAQ:PRGO) from $135.00 to $155.00 in a research note to investors on Tuesday, July 30th. They now have a “buy” rating on the stock.
Six analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $129.54.
Shares of Perrigo (NASDAQ:PRGO) traded up 0.42% on Friday, hitting $123.44. 682,965 shares of the company’s stock traded hands. Perrigo has a 1-year low of $98.79 and a 1-year high of $134.31. The stock’s 50-day moving average is $124.0 and its 200-day moving average is $120.5. The company has a market cap of $11.617 billion and a price-to-earnings ratio of 26.26.
Perrigo (NASDAQ:PRGO) last issued its quarterly earnings data on Thursday, August 15th. The company reported $1.57 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.56 by $0.01. The company had revenue of $967.20 million for the quarter, compared to the consensus estimate of $999.08 million. During the same quarter last year, the company posted $1.28 earnings per share. Perrigo’s revenue was up 16.3% compared to the same quarter last year. Analysts expect that Perrigo will post $6.55 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 17th. Shareholders of record on Friday, August 30th will be given a dividend of $0.09 per share. This represents a $0.36 dividend on an annualized basis and a yield of 0.29%. The ex-dividend date of this dividend is Wednesday, August 28th.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.